EZH2 and Hepatic fibrosis: In a study using both in vitro HSCs and in vivo carbon tetrachloride (CCL4) and bile duct ligation (BDL) liver mouse fibrosis models, treatment with DZNep to block EZH2 function led to upregulated transcription of BAMBI and blocked liver fibrosis (Jiang et al., 2021).